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Abstract
Background: Functional impairment is associated with adverse outcomes in older people, as well as in patients on
chronic hemodialysis. The aim of the present study was to determine the characteristics associated with functional
impairment in chronic hemodialysis, and to evaluate if functional impairment represents a risk factor for reduced
survival in chronic hemodialysis.
Methods: All 132 chronic hemodialysis referring to the Hemodialysis Service of the Catholic University, Rome, Italy
between November 2007 and May 2015 were included. All patients underwent comprehensive geriatric
assessment; functional ability was estimated using two questionnaires exploring independency in bathing, dressing,
toileting, transferring, continence, feeding (ADLs), and independency in using the telephone, shopping, food
preparation, housekeeping, laundering, traveling, taking medications, and handling finances (IADLs). Functional
impairment was diagnosed in presence of dependence in one or more ADLs/IADLs. Mood was assessed using the
30-item Geriatric Depression Scale. Logistic regression was used to evaluate factors associated with functional
impairment. The association between functional impairment and survival was assessed by Cox regression.
Results: ADLs impairment was present in 34 (26 %) participants, while IADLs impairment was detected in 64 (48 %)
subjects. After a follow up of 90 months, 55 (42 %) patients died. In logistic regression, depressive symptoms
were associated with ADLs and IADLs impairment (OR 1.12; 95 % CI = 1.02–1.23; OR 1.16; 95 % CI = 1.02–1.33;
respectively). In Cox regression, ADLs impairment was associated with mortality (HR 2.47; 95 % CI–1.07–5.67) while
IADLs impairment was not associated with reduced survival (HR .80; 95 % CI–.36–1.76).
Conclusions: Functional impairment is associated with depressive symptoms; also, impairment in the ADLs
represents a risk factor of reduced survival in chronic hemodialysis. These associations and their potential
implication should be assessed in dedicated studies.
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Background
Functional ability refers to a person’s ability to perform
basic tasks without assistance.
Such activities may be described as “fundamental”activ-
ities of daily living (ADLs) or instrumental activities of
daily living (IADLs) [1–3]. The ADLs explore indepen-
dency in bathing, dressing, toileting, transferring,
continence, and feeding, while the IADLs rate inde-
pendency in using the telephone, shopping, food
preparation, housekeeping, laundering, traveling, tak-
ing medications, and handling finances [1–3].
Reduced or absent functional ability is recognized as a
contributor to recurrent hospitalization and increased
mortality in the general population and in patients with
chronic diseases [4, 5].
With the aging of populations, an increasing number
of elderly patients with end-stage renal disease is starting
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dialysis. In addition, chronic hemodialysis patients de-
velop progressive functional impairment after the
initiation of replacement therapy [6]. Accordingly, im-
pairment in the ADLs, IADLs, or both affect up to 50 %
of elderly patients on chronic hemodialysis [7–9].
Definition of functional assessment is useful to define
the prognosis and the knowledge of factors associated
with functional impairment may help identify “high risk
patients” in whom therapeutic interventions might yield
a beneficial cost effectiveness profile.
Unfortunately, little is known about the characteristics
of disabled subjects on chronic hemodialysis as well as
about their prognosis [10, 11]. Thus, with the present
study, we aimed to determine the demographic, clinical
and laboratory variables associated with ADLs and/or
IADLs impairment in patients on chronic hemodialysis,
and to evaluate if ADL and/or IADL impairment repre-
sents a risk factor for increased mortality in such patients.
Methods
Study design and participants
One hundred forty nine patients on chronic thrice weekly
hemodialysis for at least 6 months at the Hemodialysis
Unit of the Catholic University, Rome, Italy, between
November 2007 and May 2015 were screened for inclu-
sion in the study. Of these, we excluded 17 patients be-
cause of: inability to answer to the questionnaires because
of deafness or reading problems (7 patients), diagnosis of
dementia (3 patients), instability of clinical conditions re-
quiring hospitalization (2 patients), and diagnosis of liver
insufficiency or active cancer (5 patients). Therefore,
complete data for the present study were available for 132
participants. The only sociodemographic characteristics in
which excluded participants differed from those included
in this study were older age (71 ± 8 years vs 62 ± 15 years;
P = .023), and a lower dialytic blood flow (270 ± 31 mL/
min vs 285 ± 25 mL/min; P = .029).
The study protocol was approved by the Ethics
Committee of the Catholic University of Rome (number:
P/607/CE; year: September/2011) and all participants pro-
vided written informed consent. The study has been per-
formed in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki. The experi-
ments comply with the current laws of Italy.
Functional ability
Functional ability was estimated using the Katz’ ADLs
[2], and the Lawton and Brody scale for IADLs [3].
These scales are used to assess functional independency
for clinical and epidemiological purposes. The ADLs
scale defines the independency in bathing, dressing, toi-
leting, transferring, continence, and feeding. A point is
given for independence in each area, up to a maximum
score of six for independence in all the domains [2]. The
IADLs scale explores independency in using the tele-
phone, shopping, food preparation, housekeeping, laun-
dering, traveling, taking medications, and handling
finances. A point is given for independence in each area,
with a total score of eight for independence in all do-
mains [3]. Impairment in the ADLs was defined as need
of assistance for performing one or more ADLs. Impair-
ment in IADL was stated as need of assistance for per-
forming one or more ADLs. Also, increasing levels of
dependency were examined, considering ADL score cut-
offs < 2, between 2 and 4, and > 4, as well as an IADL
score < 3, between 3 and 5, and >5.
Covariates
All patients were receiving conventional 4-hour
hemodialysis, three times a week. The blood flow ranged
from 250 to 300 mL/min with a dialysis rate flow of
500 mL/min. All patients were treated with high-
permeability membranes. Membranes were not reused.
Body Mass Index was calculated as weight (Kg) divided
by height squared (m2). Depressive symptoms were eval-
uated using the validated Italian version of the 30-item
Geriatric Depression Scale (GDS) [12]. Comorbidity was
assessed by the Charlson Comorbidity Index [13]. Cog-
nitive function was evaluated using the Mini Mental
State Examination (MMSE) that was administered in the
middle of the week [14, 15]. Time of recovery after
hemodialysis was also recorded asking to the patients
“How long does it take you to recover from a dialysis
session?” [16]. Blood samples were obtained after over-
night fasting immediately before the hemodialysis
session. Laboratory parameters were measured at the
Department of Laboratory Medicine, Catholic University
of Rome.
Statistical analyses
Statistical analyses were performed using SPSS for
Mac 20.0. Differences were considered significant at
the P < .050 level. The covariates to be entered into
analyses, besides their descriptive value, were chosen as
explanatory according to available reviews and meta-
analyses from the electronic databases of PubMed (MED-
LINE) and Cochrane Library, and based upon their
efficiency and economicity. Data of continuous vari-
ables are presented as mean values ± standard devi-
ation (SD). Medians and inter-quartile ranges were
provided for non-normally distributed variables. Analysis
of variance (ANOVA) for normally distributed variables
was performed according to impairment in the ADLs;
otherwise, the nonparametric Mann–Whitney U test was
adopted. The two-tailed Fisher exact test was used for di-
chotomous variables. Pearson’s correlation analysis was
performed to assess the correlation of serum creatinine
levels, serum albumin levels and Body Mass Index.
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Multivariable logistic regression analysis was adopted
to estimate the association of ADLs and IADLs impair-
ment with age, sex, and all those variables, which dif-
fered significantly (P < .05) in univariate analyses. Also,
multivariable logistic regression was used to assess
the association between depression (i.e. 30 item GDS
score >11) and increasing levels of functional impair-
ment. Survival analysis was performed using the Kaplan-
Meyer method. Univariate analysis was performed in
order to examine the relationship between potential
predictor variables and death. Variables associated to
mortality were included as potential confounders in a
multivariable Cox proportional hazard regression ana-
lysis. In addition, to avoid any possible inflated association
of patients who die early (i.e. first six months of follow-
up) the same Cox analysis was ran after the exclusion of
these subjects. The area under the ROC curve was
adopted to compare if and how the models perform.
As malnutrition and low muscle mass are acknowledged
risk factors for functional impairment and mortality, and
creatinine levels are known to reflect both conditions, the
dependency of the association between functional ability
and survival upon creatinine levels was assessed by the
analysis of the interaction term “ADLs*serum creatinine”
using the multivariable Cox model. In addition, Cox
regression analysis was also adopted to evaluate the ad-
justed association between increasing levels of func-
tional impairment (ADL score: 0–2, 2–4, and ≥ 4; IADL
score 0–3, 3–5, and ≥ 5) and survival.
Results
Impairment in the ADLs was recorded in 34/132 (26 %)
patients, while impairment in the IADLs was detected in
64/132 (48 %) patients. Impairment in five ADLs was
found in 1 (0.7 %) subject, in four ADLs in 4 (3 %) par-
ticipants, and in three ADLs in 11 (8.1) subjects; impair-
ment in two ADLs was established in 5 (3.7 %) patients,
and in one ADL in 13 (9.6 %) participants.
In particular, impairment in the ability of bathing was
present in 1 patient, in dressing in 19 subjects, in toilet-
ing in 18 participants, in the ability of transferring in 5
patients, in continence in 34 subjects, and impaired
feeding in 1 participant.
Also, an impairment in all IADLs was found in 1
(0.7 %) patient; impairment in seven IADLs was detected
in 5 (3.7 %) subjects, in six IADLs in 9 (6.7 %) partici-
pants, in five IADLs in 14 (10.4 %) subjects, in four
IADLs in 9 (6.7 %) patients, in three IADLs in 9 (6.7 %)
subjects, in two IADLs in 13 (9.6 %) subjects, and in one
IADL in 4 (3 %) subjects.
Eventually, impairment in the ability of using the tele-
phone was present in 1 patient, impairment in the ability
of shopping in 43, impairment in the ability of food
preparation in 45, impairment in the ability of
housekeeping in 47, impairment in the ability of laun-
dering in 45, impairment in the ability of traveling in 35,
impairment in the ability of taking medications in 28,
and impairment in the ability of handling finances in 21.
After a follow-up of 90 months, 55 (42 %) patients died
(of those, 7 subjects died within the first six months),
while 11/132 (8 %) patients were transplanted. The me-
dian ADL and IADL scores were lower in participants
who died as compared with survivors (ADL: 4, 3–5 vs 5,
4–6; P < .0001; IADL 4, 3–8 vs 7, 6–8; P < .001).
Cross sectional analyses
The characteristics of patients according to the presence
of ADLs impairment are depicted in Table 1. Patients
with ADL impairment had a higher GDS score as com-
pared with patients without ADL impairment. In
addition, they showed lower creatinine serum levels.
The characteristics of patients according to the pres-
ence of IADLs impairment are shown in Table 2. Pa-
tients with IADL impairment had a higher GDS score
and lower creatinine serum levels than patients without
IADL impairment.
According to logistic regression analysis, ADLs impair-
ment was associated with depressive symptoms expressed
by the 20-item GDS in crude model (OR 1.19; 95 % CI =
1.09–1.29), adjusting for age and sex (OR 1.16; 95 % CI =
1.06–1.27) and in the fully adjusted model (OR 1.12; 95 %
CI = 1.02–1.23; Table 3), adjusted for those variables
which showed significant differences in univariate ana-
lyses. Also, IADLs impairment was associated with the
GDS score in crude model (OR 1.24; 95 % CI–1.14–1.34),
adjusting for age and sex (OR 1.20; 95 % CI = 1.10–1.31)
and in the fully adjusted model (OR 1.16; 95 % CI = 1.02–
1.33; Table 3), adjusted for those variables which showed
significant differences in univariate analyses.
Eventually, depression was not associated with increas-
ing level of ADLs impairment (P for trend–.14).
Prospective analyses
Patients who died, as compared with survivors, had an
higher GDS score (13 ± 5 vs 8 ± 6; P = <.01), lower
creatinine serum levels (8.6 ± 2.2 vs 10.7 ± 3.0 mg/dL;
P < .01), and an higher prevalence of functional im-
pairment both in the ADLs (28, 51 vs 6, 8 %; P < .01)
and IADLs (37, 67 vs 27, 35 %; P < .01).
In Kaplan Meier analysis the log rank test indicated
that survival differed significantly according to func-
tional impairment (ADLs: χ2 (2) = 39.0; P < .01; IADLs:
χ2 (2) = 13.8; P < .01).
According to the multivariable Cox regression model,
survival was significantly reduced in patients with ADLs
impairment; no significant differences in survival were
detected among participants with IADLs impairment. In
fact, according to multivariable Cox regression analysis
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Table 1 Characteristics of 132 participants according to the presence of impairment in the Activities of Daily Living (ADLs;
impairment was defined as an ADLs score <6). (Study center: Catholic University, Rome, 2007–2015)
Patients with ADLs impairment (n = 34) n (%),
mean ± SD, or median and interquartiles
Patients without ADLs impairment (n = 98) n (%),
mean ± SD, or median and interquartiles
P
Age (years) 71 ± 11 61 ± 15 <.01
Sex (female) 14 (41 %) 35 (36 %) .68
Dialytic age (months) 36 (12–84) 36 (12–83) .79
Body Mass Index (Kg/m2) 25.6 ± 4.7 24.5 ± 4.4 .22
Charlson comorbidity index score 4 (2–5) 2 (1–3) <.01
Diabetes 15 (44 %) 26 (27 %) .08
Geriatric Depression Scale 15 ± 6 9 ± 6 <.01
Mini Mental State Examination 22 ± 4 24 ± 3 <.01
Kt/V 1.2 ± 0.3 1.3 ± 0.2 .07
Dialytic blood flow (mL/min) 284 ± 27 284 ± 25 .92
Time of recovery after hemodialysis (min) 210 (60–720) 180 (60–360) .28
Hemoglobin (g/dL) 11.2 ± 1.2 11.0 ± 1.5 .46
Serum creatinine (mg/dL) 8.5 ± 2.2 10.3 ± 3.0 <.01
Serum albumin (g/dL) 3.8 ± 0.3 4.0 ± 0.3 <.01
Serum calcium (mg/dL) 8.7 ± 0.6 9.0 ± 0.6 .11
Serum phosphorus (mg/dL) 5.6 ± 1.6 5.3 ± 1.8 .49
Serum PTH (mg/dL) 245 (110–350) 278 (146–417) .21
Serum bicarbonate (mEq/L) 23.5 ± 1.9 24.0 ± 1.8 .20
Table 2 Characteristics of 132 participants according to the presence of impairment in the Instrumental Activities of Daily Living
(IADLs; defined as and IADLs score < 8). (Study center: Catholic University, Rome, 2007–2015)
Patients with IADLs impairment (n = 64) n (%),
mean ± SD, or median and interquartiles
Patients without IADLs impairment (n = 68) n (%),
mean ± SD, or median and interquartiles
P
Age (years) 70 ± 11 57 ± 15 <.01
Sex (female) 29 (45 %) 20 (29 %) .07
Dialytic age (months) 40 (12–88) 36 (12–75) .66
Body Mass Index (Kg/m2) 24.9 ± 4.4 24.7 ± 4.6 .82
Charlson comorbidity index score 3 (2–4) 2 (1–3) <.01
Geriatric Depression Scale 14 ± 6 7 ± 5 <.01
Mini Mental State Examination 22 ± 4 24 ± 3 <.01
Kt/V 1.3 ± 0.2 1.2 ± 0.2 .67
Dialytic blood flow (mL/min) 281 ± 27 288 ± 24 .12
Time of recovery after hemodialysis (min) 210 (112–480) 120 (30–300) .02
Hemoglobin (g/dL) 10.9 ± 1.8 11.3 ± 1.1 .17
Serum creatinine (mg/dL) 8.7 ± 2.2 10.8 ± 3.1 <.01
Serum albumin (g/dL) 3.8 ± 0.3 4.0 ± 0.2 <.01
Serum calcium (mg/dL) 8.9 ± 0.6 9.0 ± 0.6 .30
Serum phosphorus (mg/dL) 5.0 ± 1.5 5.7 ± 1.9 .06
Serum PTH (mg/dL) 265 (123–429) 260 (143─361) .90
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(Fig. 1), impairment in the ADLs was associated with in-
creased risk of mortality in crude model (HR 5.03; 95 %
CI = 2.87–8.82), in a model adjusted for age and sex (HR
3.47; 95 % CI = 1.89–6.35) and in the fully adjusted
model (HR 2.47; 95 % CI–1.07–5.67; Table 4), adjusted
for those variables which showed significant differences
in univariate analyses. In addition, similar results were
observed after the exclusion of patients who died in the
first six months of follow–up (crude model: HR 5.79;
95 % CI = 3.16–10.61; age and sex-adjusted: HR 3.85;
95 % CI = 2.00–7.40; fully adjusted HR 3.04; 95 % CI–
1.26–7.38). The area under the ROC curve indicated
that ADLs impariment was an useful predictor of
death in all participants (0.72) and after the exclusion
of subjects who died in the first six months of follow-
up (0.71).
A significant association between mortality and IADLs
impairment was found only in the crude model (HR
2.79; 95 % CI = 1.58–4.91), but not in the age–and sex
adjusted model (HR 1.59; 95 % CI = .85–2.96) nor in the
fully adjusted model (HR .80; 95 % CI–.36–1.76,
Table 4).
Similar results were observed after the exclusion of pa-
tients who died during the first six months of follow-up
(crude model: HR 3.08; 95 % CI = 1.67–5.70; age and
sex-adjusted: HR 1.76; 95 % CI = .90–3.44; fully adjusted
HR .89; 95 % CI = .40–1.99). The area under the ROC
curve confirmed that IADLs impariment was a poor pre-
dictor of death in all participants (0.66), as well as after
excluding participants who died during the first six
months of the follow-up (0.65).
In addition, according to Cox regression models, cre-
atinine serum levels were associated with decreased
mortality (model with ADLs impairment: HR .85; 95 %
CI = .73–.99; model with IADLs impairment HR .81;
95 % CI = .69–.94), while age was associated with mor-
tality only in the model that included IADLs impairment
(HR 1.06; 95 % CI = 1.01–1.12). No significant
Table 3 Association (OR coefficients, and 95 % confidence
intervals, CI) of functional impairment with the variables of
interest according to logistic multivariable regression model. All
the covariates were entered simultaneously into the regression
model. (Study center: Catholic University, Rome, 2007–2015)
ADLs impairment IADLs impairment
OR 95 % CI OR 95 % CI
Age (years) 1.05 .98–1.13 1.01 .95–1.07
Sex (female) .92 .28–3.05 2.77 .69–11.05
Charlson comorbidity
index score
1.28 .92–1.78 1.26 .86–1.85
Mini Mental State
Examination
.97 .83–1.13 .78 .58–1.06
Serum creatinine (mg/dL) .85 .66–1.10 .78 .57–1.06
Serum albumin (g/dL) .91 .15–5.66 .89 .08–9.91
Time of recovery after
hemodialysis (min)
1.21 .72–2.05
Geriatric Depression Scale 1.12 1.02–1.23 1.16 1.02–1.33
Fig. 1 Survival curves according to the multivariable Cox regression model for increasing levels of ADLs and IADLs impairment. (Study center:
Catholic University, Rome, 2007–2015)
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association was found for the other covariates included
in the adjusted Cox regression model. Also, the analysis
of the interaction term indicated (P-.30) that the ad-
justed association between ADLs impairment and mor-
tality did not vary according to creatinine serum levels.
In addition, to avoid any possible inflated association of
patients who died early (i.e. first six months of follow-
up), the same cox model was run after the exclusion of
these subjects.
Eventually, according to crude Cox regression, increas-
ing impairment in the ADL score (P for trend < .01) as
well as in the IADL score (P for trend < .01) was associ-
ated with reduced survival.
Discussion
Results of the present study indicate that functional im-
pairment is a highly prevalent condition in hemodialysis
patients and that it is associated with reduced survival.
Moreover, the presence of depression is associated with
an increased probability of being disabled.
Little is known about the functional status of end stage
renal disease patients receiving chronic hemodialysis. In
fact, only few studies have investigated and defined the
prevalence and the correlates of functional impairment
in patients on chronic hemodialysis [6–9]. In keeping
with previous studies which estimated a prevalent func-
tional impairment ranging from 19 to 59 %, our data in-
dicate a high prevalence of functional impairment in the
ADLs, IADLs or both. Kurella Tamura et al. [6] have
shown that the initiation of dialysis is associated with
substantial and sustained decline of functional status in
patients with end-stage renal disease who were living in
nursing home; functional status was measured by asses-
sing the degree of dependence in seven activities of daily
living. Recently, Kavanagh et al. have shown that stroke,
cognitive impairment, and higher systolic blood pressure
were independent correlates of ADLs and IADLs impair-
ment, while demographic characteristics, chronic health
conditions, depressive symptoms or laboratory measure-
ments were not [8]. The study of Kutner et al.
demonstrated an increased probability of need for ADLs
assistance in frail and prefrail hemodialysis patients, as
well as in those with diabetes, lung disease, and stroke [9].
The results of the present study are intriguing, because
depression might be a potentially reversible factor that
might be easily and early identified after the onset of
hemodialysis [17]. In fact, several previous studies con-
firm that serotonin-selective reuptake inhibitors may be
safe also in patients with end-stage renal disease [17]. In
addition, not-pharmacological treatments such as fre-
quent hemodialysis, cognitive behavioral therapy, phys-
ical training programs, treatment of anxiety, and music
therapy have led to promising results [17].
An association of ADLs and IADLs impairment with
depressive symptoms or depression has been found in
the general population, in older individuals, as well as
and in patients with chronic diseases [18–24]. In older
age, functional impairment and depression appear to co-
exist through a reciprocal relationship [18–24]. In fact,
Bruce et al. found that depressive symptoms were associ-
ated with increased risk of functional impairment in
community-dwelling elderly subjects [18]. However, par-
ticipants were high-functioning men and women, and
only ADLs impairment was assessed; on the contrary,
our patients might be classified as “frail” patients. Also,
Ormel et al. recognized three possible relationships be-
tween functional and depression, and concluded that
functional impairment and depressive symptoms are
mutually reinforcing over time [19]; however, their study
included community dwelling elderly with significant
initial physical limitations. Both ADLs and IADLs im-
pairment were considered. In addition, Armenian et al.
found an association between psychopathology and ADL
impairment, only [20]; however, their study enrolled
community dwelling participants, not only elderly, and
major depression as well as other psychopathological
conditions were taken into account. Barry et al. have
identified an association between the severity of de-
pressive symptoms and the burden of functional im-
pairment [21]; the study included community dwelling
Table 4 Hazard ratio (HR) and 95 % confidence intervals (CI) of mortality at 90 months according to Cox regression models. All the
covariates were entered simultaneously into the regression models. (Study center: Catholic University, Rome, 2007–2015)
HR 95 % CI HR 95 % CI
ADLs impairment 2.47 1.07–5.67 IADLs impairment .80 .36–1.76
Age (years) 1.05 .99–1.10 Age (years) 1.06 1.01–1.12
Sex (female) 1.88 .93–3.81 Sex (female) 1.66 .83–3.33
Charlson comorbidity index 1.11 .92–1.33 Charlson comorbidity index 1.16 .96–1.39
Geriatric Depression Scale 1.04 .98–1.11 Geriatric Depression Scale 1.06 .99–1.13
MMSEa 1.04 .93–1.17 MMSEa .99 .89–1.11
Serum creatinine (mg/dL) .85 .73–.99 Serum creatinine (mg/dL) .81 .69–.94
Serum albumin (g/dL) .70 .21–2.27 Serum albumin (g/dL) .72 .22–2.38
a Mini Mental State Examination
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elderly, and functional impairment was estimated only
through ADLs.
Functional impairment may cause psychological dis-
tress, and depression may in turn lead to functional im-
pairment through several mechanisms, such as reduction
in motivation and help seeking, and changes in neural,
hormonal and immunological systems which increase
susceptibility to disease. Interestingly, a recent review
has provided strong support for the bidirectional rela-
tionship between depression, functional ability and
frailty in later life [24].
The present study also shows that impairment in the
ADLs, but not IADLs, represents a risk factor for re-
duced survival in patients on chronic hemodialysis.
These findings are consistent with previous observations
that ADLs impairment is independently associated with
higher mortality in patients on chronic hemodialysis
[10]. It has also been demonstrated that the deterior-
ation of even a single point of ADL on admission com-
bined with age is highly predictive of poor outcomes in
hospitalized dialysis patients [25]. Accordingly, func-
tional impairment assessed by other tools has also been
associated with higher mortality in patients on chronic
hemodialysis [26, 27]. It has been proposed that rehabili-
tation through education, cognitive, physical, and psy-
chosocial interventions might prevent, reverse or delay
the onset of functional impairment with ensuing adverse
outcomes in elderly dialysis patients, and thus should be
incorporated routinely into standard dialysis care [28].
In our study, the absence of an association between
mortality and functional impairment in the IADLs is
noteworthy. Of notice, previous studies have indicated
that impairment in the ADLs is a more sensitive risk fac-
tor for reduced survival in frailer patients [29, 30]. In
fact, Mossakowska et al. found that ADLs, but not
IADLs, predicted survival in a cohort of centenarians
[29]. Delgado Parada et al. established that among
patients hospitalized for heart failure the only variable
independently associated with higher 1-year mortality
risk was pre-admission dependence in performing the
ADLs [30]. In addition, Sonmez et al. have ascertained
that only the ADLs scale was a determinant of prognosis
and survival in patients with breast cancer [31].
The evidence that higher serum creatinine levels were
associated with increased survival and absence of func-
tional impairment might deserve some concern. How-
ever, higher serum creatinine levels might reflect better
nutritional status and higher lean body mass [32]; on the
other hand, malnutrition and low muscle mass are ac-
knowledged risk factors for both functional impairment
and mortality [33, 34]. To confirm this hypothesis, in
our population there was a significant positive correl-
ation between serum albumin and creatinine levels. In-
deed, no correlation between creatinine levels and body
mass index was found; however, the body mass index is
not a good indicator of muscle mass [35].
The present study has some limitations. First, the sam-
ple size was relatively small, which may make any
generalization difficult. This limitation, which is reflected
by the width of some confidence intervals, also restricted
the number of covariates that could be entered into the
regression models. Second, we don’t know the dynamic
nature of functional impairment, and consequently we
may have included both patients with transient func-
tional impairment and those with chronic, persistent
functional impairment. However, it is well known that
self-reported functional ability is valid in non-dialysis
populations and it has been shown to be useful and valid
also in patients on chronic hemodialysis [9, 10].
Conclusion
The present study shows that impairment in ADLs and
IADLs is a common finding, independently associated
with depressive symptoms. ADL impairment represents
a risk factor for reduced survival in patients on chronic
hemodialysis. Further studies are needed to better under-
stand the mechanisms underlying such associations and
to identify subjects who might benefit from interventions
aimed at improving survival.
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